Erratum to “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study”

In the article titled “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study” [1], “IGT N = 2” in the Post SSA column in Figure 1 was incorrect due to a production error and should be “IGT N = 12”. The updated Figure 1 is as follows:

Figure 1.

Flowchart of prevalence of NGT, IGT, and DM at pretreatment and after SSA treatment, and the change of glucose metabolism status after SSA therapy. NGT: normal glucose tolerance; IGT: impaired glucose tolerance; DM: diabetes mellitus.